Researchers from the University of Zurich have developed an AI-driven gene editing method that improves DNA repair predictions, enabling more accurate and safer genome modifications.
Karolinska Institutet researchers analysed DNA from nearly one million people and found genetic variants tied to brain function, immune defence, and metabolism that raise the risk of frailty in old age.
A first-in-patient trial using AAV-based OTOF gene therapy, led by Karolinska Institutet and Chinese hospitals, restored hearing (improving from 106 dB to 52 dB) in 10 individuals aged 1–24.
The University of Edinburgh's new £5 million hub at the Roslin Institute aims to revolutionise livestock farming through precision breeding, gene editing, and AI, enhancing sustainability and disease resilience.
A Stanford-led phase 3 trial shows gene therapy skin grafts significantly heal chronic wounds in patients with severe epidermolysis bullosa, reducing pain and improving quality of life.
There is a beacon of hope for patients with a rare genetic disorder called Werner Syndrome as researchers unveil a groundbreaking discovery: Nicotinamide riboside, a vitamin B3 derivative, reverses premature ageing.
A groundbreaking study from the Paul Scherrer Institute (PSI) in collaboration with Inselspital–Bern University Hospital has unveiled a promising new therapy for lymphoma using the radioactive isotope terbium-161.
Groundbreaking AI models are now deciphering plant DNA, treating genetic sequences like language. This innovation promises to revolutionise genomics and agriculture, offering unprecedented insights into plant biology and accelerating crop improvement for global food security.
Steven T. Reed, O.D., President of the American Optometric Association, discusses age-related macular degeneration (AMD), the leading cause of severe vision loss in adults over 50, and the importance of early diagnosis and preventive care.
Amidst a stark rise in US syphilis cases, researchers have secured a $2.7 million NIH grant to develop the first comprehensive, rapid test for active infection that aims to deliver accurate results within 10 minutes.
Researchers from the University of Cambridge and the NIHR Cambridge Biomedical Research Centre have created an algorithm that finds vulnerable cancer tumours.
Cancer cells are masters of disguise, evading immune destruction through cunning mechanisms. Groundbreaking research reveals a novel tactic: mitochondrial transfer. Cancer cells cripple immune cells by donating their damaged mitochondria, hindering the immune response and fostering tumour growth.
